Education
About Us
Working with TipRanks
Follow Us
Keymed Biosciences, Inc. (HK:2162)
:2162
Comparison Results
Keymed Biosciences, Inc.
HK$62.80
HK$16.92B
―
38.03%
6 Buy
0 Hold
0 Sell
Strong Buy
Ascletis Pharma, Inc.
HK$9.65
HK$9.11B
-32.00
584.40%
3 Buy
1 Hold
0 Sell
Strong Buy
Simcere Pharmaceutical Group Limited
HK$12.36
HK$34.19B
33.94
80.70%
4 Buy
1 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$16.48
HK$9.98B
―
244.05%
1 Buy
0 Hold
0 Sell
Moderate Buy
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$22.76
HK$11.11B
77.71
348.72%
―
Performance Comparison
HK:2162
Keymed Biosciences, Inc.
60.25
15.90
35.85%
HK:1672
Ascletis Pharma, Inc.
9.65
8.21
570.14%
HK:2096
Simcere Pharmaceutical Group Limited
12.36
5.60
82.84%
HK:2157
Lepu Biopharma Co. Ltd. Class H
6.35
3.27
106.17%
HK:2171
CARsgen Therapeutics Holdings Ltd.
16.48
11.73
246.95%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
28.00
21.92
360.53%